Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Heritage Cannabis Signs Genetics Agreement with CannTrust

Stockhouse Editorial
0 Comments| November 14, 2018

{{labelSign}}  Favorites
{{errorMessage}}

Heritage Cannabis Holdings Corp. (CSE:CANN,Forum) on Wednesday stated that has executed a one-year ‘Supply and Purchase’ agreement with CannTrust Inc. through its subsidiary CannaCure Corp. for the immediate delivery of cannabis genetics. CannaCure will purchase one of CannTrust’s most popular strains. The agreement also allows for CannaCure, to request an increase in the number of clones it receives.

For more information on this, click here.

CANN made news recently when it announced that its other subsidiary, PhyeinMed Inc., received its updated license in accordance with Health Canada’s Cannabis Act and Cannabis Regulations.


FULL DISCLOSURE: Heritage Cannabis Holdings Corp.is a paid client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company